HOME >> BIOLOGY >> NEWS
Mutant mice lead to memory insights

Two strains of mutant mice with crippled versions of a key memory molecule have led researchers to an understanding of both normal memory function and the memory problems that plague sufferers of an inherited disorder.

The researchers said their findings suggest that drugs already being tested for cancer and Huntington's disease might be useful in restoring some memory capability to patients with Rubinstein-Taybi syndrome (RTS). RTS is a heritable disorder characterized by mental and growth retardation and skeletal abnormalities. In humans, RTS occurs in about one in 125,000 births. The researchers propose that their findings could lead to treatments for RTS and other memory disorders as well as a means of improving memory in otherwise healthy individuals.

Two groups of researchers independently studied mutant mice deficient in "CREB binding protein" (CBP), which is a common target in patients with RTS. CBP is so named because it binds a key gene-regulating protein called CREB that is important for many functions including memory in animals from mollusks to humans.

CBP is a particularly hard-working protein. It serves as a molecular scaffold that helps assemble the machinery of gene transcription known to be necessary for formation of long-term memories. And critically, CBP acts as an enzyme that transfers acetyl groups onto the histone proteins that are part of the chromatin enfolding DNA in the chromosomes. Such acetylation is a central process in remodeling the chromatin to prepare the chromosome for gene transcription.

In one paper, Eric Kandel and his colleagues studied a mutant mouse -- developed in another laboratory -- in which one of the two copies of the gene for CBP had been knocked out. Such "haploinsufficiency" is thought to be a good animal model for Rubinstein-Taybi syndrome, because it mimics many of the symptoms of the disease.

In their studies, the researchers sought to understand whether such haploinsuffi
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
23-Jun-2004


Page: 1 2 3

Related biology news :

1. Mutant biological machine makes proteins but cant let go
2. Mutant gene linked to obsessive compulsive disorder
3. Mutant gene found to cause early ovarian failure in mice
4. Mutants from a lowly weed may solve maladies
5. Mutant proteins may be key to defeat chemical warfare
6. Protein Misfolding, Not Mutant Gene, Key To Lethal Sleep Disorder
7. Mechanism Discovered For Determining Early Vertebrate Body Plan: New Zebrafish Mutants Afford Deeper Look Into Embryonic Patterning
8. MITs Mini Respirator Breathes Life Into Mutant Mice
9. Induced Mutant Mouse Models Of Lipoprotein Disorders And Atherosclerosis
10. Mutant Gene Not Sole Explanation For Hiv Non-Progression
11. Single Mechanism Seen To Underlie Group Of Neurodegenerative Diseases: Mutant Proteins Form Insoluble Masses In The Nuclei Of Neurons

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... ... May 21, 2019 , ... At their May 16 ... Tissue Engineered Medical Products (TEMPs) of the American Society for Testing and Materials ... Gaining this approval was the next step in the company’s plan to establish ...
(Date:5/14/2019)... ... May 13, 2019 , ... BioMedGPS is excited to ... Pre-EWMA 2019 event at Gothenburg’s Universeum Aquarium. Guests will be treated to an ... Advanced Wound Care. , SmartTRAK’s Advanced Wound Care Experts will serve as panelists. ...
(Date:5/8/2019)... (PRWEB) , ... May 08, 2019 , ... ... – has successfully leveraged the support services provided by Medrio , the ... a clinical trial sponsor agreement. , By collaborating to position high-quality CRO ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... LOVELAND, Ohio (PRWEB) , ... April 15, 2019 ... ... and oligomers, has completed construction of a $2 million bench plant expansion to ... represents an important step in the design and construction of Sirrus’ full-scale production ...
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life Sciences ... life sciences organizations to accelerate innovation and maximize productivity, announces that nearly 100 ... 12 months. , USDM’s Cloud Assurance is a managed subscription service ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities , an ... equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has ... at female hypoactive sexual dysfunction disorder and is ready to begin phase 2b trials. ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
Breaking Biology Technology:
Cached News: